Sueli Carneiro

Sueli Carneiro

Auto-generated profile, based on publicly available information

Sueli Carneiro

UNIFAMETRO

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2018 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ABAline L. Bressan
Aline L. Bressan
Bruna Lavinas Sayed PiccianiBruna Lavinas Sayed Picciani
Bruna Lavinas Sayed Picciani
LALuna Azulay‐Abulafia
Luna Azulay‐Abulafia
AFAnna Fausto
Anna Fausto
PAPaula N. Almeida
Paula N. Almeida
SCSueli Carneiro
Sueli Carneiro

1 January 2015 in Revista Brasileira de Reumatologia
Verified
Journal Article
Open access
ICIzaias Pereira da Costa
Izaias Pereira da Costa
ABAdriana B. Bortoluzzo
Adriana B. Bortoluzzo
CGCélio R. Gonçalves
Célio R. Gonçalves
JSJosé Antonio Braga da Silva
José Antonio Braga da Silva
AXAntonio Carlos Ximenes
Antonio Carlos Ximenes
PSPercival D. Sampaio‐Barros
Percival D. Sampaio‐Barros
To analyze the results of the application of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in a large series of Brazilian patients with the diagnosis of SpA and establish its correlations with specific variables into the group. A common protocol of investigation was prospectively applied to 1492 Brazilian patients classified as SpA according to the European Spondyoarthropathies Study Group (ESSG), attended at 29 referral centers of Rheumatology in Brazil. Clinical and demographic variables, and disease indices (BASDAI, Basfi, Basri, Mases, ASQol) were applicated. The total values of BASDAI were compared to the presence of the different variables. The mean score of BASDAI was 4.20 ± 2.38. The mean scores of BASDAI were higher in patients with the combined (axial + peripheral + entheseal) (4.54 ± 2.38) clinical presentation, compared to the pure axial (3.78 ± 2.27) or pure peripheral (4.00 ± 2.38) clinical presentations (p<0.001). BASDAI also presented higher scores associated with the female gender (p<0.001) and patients who did not practice exercises (p < 0.001). Regarding the axial component, higher values of BASDAI were significantly associated with inflammatory low back pain (p<0.049), alternating buttock pain (p<0.001), cervical pain (p<0.001) and hip involvement (p<0.001). There was also statistical association between BASDAI scores and the peripheral involvement, related to the lower (p=0.004) and upper limbs (p=0.025). The presence of enthesitis was also associated to higher scores of BASDAI (p=0.040). Positive HLA-B27 and the presence of cutaneous psoriasis, inflammatory bowel disease, uveitis and urethritis were not correlated with the mean scores of BASDAI. Lower scores of BASDAI were associated with the use of biologic agents (p<0.001). In this heterogeneous Brazilian series of SpA patients, BASDAI was able to demonstrate "disease activity" in patients with axial as well as peripheral disease.

1 May 2013 in Revista Brasileira de Reumatologia
Verified
Journal Article
Open access
SCSueli Carneiro
Sueli Carneiro
VAValderilio Azevedo
Valderilio Azevedo
RGRubens Bonfi Glioli
Rubens Bonfi Glioli
RRRoberto Ranza
Roberto Ranza
CGCélio Roberto Gonçalves
Célio Roberto Gonçalves
PSPercival Degrava Sampaio-Barros
Percival Degrava Sampaio-Barros
Descrição do método de elaboração das evidênciasOs integrantes da Comissão de Espondiloartrites da Sociedade Brasileira de Reumatologia (biênio 2010-2012) participaram do Curso de Elaboração de Evidências da Associação Médica Brasileira, em São Paulo, durante o primeiro semestre de 2011. As questões foram concluídas em reunião presencial da Comissão de Espondiloartrites no dia 15 de outubro de 2011, durante a XVIII Jornada Cone Sul de Reumatologia, em Florianópolis (SC), e foram posteriormente aprovadas por todos os coordenadores do Registro Brasileiro de Espondiloartrites. As 15 questões clínicas consideradas relevantes foram estruturadas por meio da estratégia do P.I.C.O. (paciente; intervenção ou indicador; comparação; outcome). As estratégias de busca avaliaram as bases de dados MEDLINE, EMBASE, Scielo/Lilacs, Cochrane Library até fevereiro de 2012 (Apêndice). Os artigos selecionados na primeira estratégia de busca foram submetidos à avaliação crítica das evidências, utilizando-se o escore de Jadad. Posteriormente, foram elaboradas as respostas às perguntas das Recomendações, sendo que cada referência bibliográfica selecionada apresentava o correspondente grau de recomendação e força de evidência científica. Para as Recomendações finais, as referências bibliográficas foram atualizadas até agosto de 2012, redigidas em texto único pelo coordenador, e submetidas aos coautores em dois turnos, para elaboração do texto final.Grau de recomendação e força de evidênciaA:Estudos experimentais e observacionais de melhor consistência.B:Estudos experimentais e observacionais de menor consistência.C:Relatos de casos (estudos não controlados).D:Opinião desprovida de avaliação crítica, baseada em consensos, estudos fisiológicos ou modelos animais.ObjetivoEstabelecer as recomendações para o diagnóstico (critérios classificatórios e avaliação clínica) e o tratamento da artrite psoriásica

1 January 2014 in Clinics in Dermatology
Verified
Journal Article
Closed access
MRMarcia Ramos-E-Silva
Marcia Ramos-E-Silva
ASAna Luisa Sampaio
Ana Luisa Sampaio
SCSueli Carneiro
Sueli Carneiro

1 May 2014 in Revista Brasileira de Reumatologia
Verified
Journal Article
Open access
PDF file
WBWashington A. Bianchi
Washington A. Bianchi
FEFernanda R. Elias
Fernanda R. Elias
GPGeraldo da Rocha Castelar Pinheiro
Geraldo da Rocha Castelar Pinheiro
CGCarlos Roberto Machado Gayer
Carlos Roberto Machado Gayer
CCClaudio Carneiro
Claudio Carneiro
SCSueli Carneiro
Sueli Carneiro
Objectives: Fatigue is a highly subjective and extremely common symptom in patients with rheumatoid arthritis although it is difficult to characterize and define. The aim of this study was to assess fatigue in a cohort of Brazilian patients, and to analyze the relationship be- tween fatigue and disease-specific variables. Methods: 371 Brazilian patients diagnosed with rheumatoid arthritis according to the 1987 American College of Rheumatology classification criteria were prospectively investigated. Demographic, clinical and laboratorial data were obtained from hospitals records. The number of painful joints, bone mass index, disease duration, quality of life, functional ca- pacity, anxiety and depression were recorded. Fatigue was evaluated using the subscale of Fatigue Assessment of Chronic Illness Therapy (FACIT-FATIGUE scale). Results: The median fatigue score was 42.0 (10.0), negatively correlated with functional ca- pacity (-0.507; P < 0.001), anxiety and depression (-0.542 and -0.545; P < 0.001 respectively), and predominantly with physical domain of Short Form 36-item quality of life question- naire (SF-36P: 0.584; P < 0.001). The scores were not associated with the erythrocyte sedi- mentation rate (-0.118; P < 0.05), C-reactive protein (-0.089; P < 0.05), disease activity (-0.250; P < 0.001) or the number of painful joints (-0.135; P < 0.01). Confidence interval of 95% was applied for all measures. Conclusions: In this series of Brazilian patients with rheumatoid arthritis, we suggest a new significance for fatigue complains as an independent parameter not related with number of painful joints, disease or inflammatory activity scores. Psychological and functional impairments appear to be more related to fatigue. Additional studies and inclusion of stan- dard measures for monitoring fatigue complains are required. Objetivos: A fadiga é um sintoma altamente subjetivo e extremamente comum em pacien- tes com artrite reumatoide, embora seja difícil de caracterizar e definir. O objetivo desse estudo foi avaliar a fadiga em uma coorte de pacientes brasileiros e analisar a relação entre fadiga e variáveis específicas da doença. Métodos: Foram prospectivamente investigados 371 pacientes brasileiros diagnosticados com artrite reumatoide, de acordo com os critérios de classificação do Colégio Americano de Reumatologia de 1987. Dados demográficos, clínicos e laboratoriais foram obtidos dos registros clínicos. Foram registrados o número de articulações dolorosas, índice de massa corporal, duração da doença, qualidade de vida, capacidade funcional, ansiedade e depres- são. A fadiga foi avaliada com o uso da subescala específica da escala Fatigue Assessment of Chronic Illness Therapy (FACIT-FATIGUE). Resultados: O escore mediano para fadiga foi 42 (10), negativamente correlacionado com a capacidade funcional (-0,507; p < 0,001), ansiedade e depressão (-0,542 e -0,545; p < 0,001, respectivamente) e predominantemente com o domínio físico do questionário Short Form- 36 para qualidade de vida (SF-36P: 0,584; p < 0,001). Não houve correlação entre os escores e a velocidade de sedimentação das hemácias (-0,118; p <0,05), proteína C reativa (-0,089; p < 0,05), atividade da doença (-0,250;p < 0,001) ou número de articulações dolorosas (-0,135; p < 0,01). Para todas as medidas foi aplicado um intervalo de confiança de 95%. Conclusões: Nesta série de pacientes brasileiros com artrite reumatoide, sugerimos um novo significado para as queixas de fadiga como um parâmetro independente não relacionado com o número de articulações dolorosas ou escores de atividade inflamatória. Parece ha- ver maior relação entre transtornos psicológicos e funcionais com a fadiga. Seriam impor- tantes novos estudos e uso rotineiro de medidas padronizadas para a monitorização das queixas de fadiga.

19 January 2021 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
RLRicardo da Cruz Lage
Ricardo da Cruz Lage
CMClaudia Diniz Lopes Marques
Claudia Diniz Lopes Marques
TOThauana Luiza Oliveira
Thauana Luiza Oliveira
GRGUSTAVO Gomes RESENDE
GUSTAVO Gomes RESENDE
CKCharles Lubianca Kohem
Charles Lubianca Kohem
MPMarcelo M Pinheiro
Marcelo M Pinheiro
Spondyloarthritis (SpA) is a group of chronic inflammatory systemic diseases characterized by axial and/or peripheral joints inflammation, as well as extra-articular manifestations. Over some decades, nonsteroidal anti-inflammatory drugs (NSAIDs) have been the basis for the pharmacological treatment of patients with axial spondyloarthritis (axSpA). However, the emergence of the immunobiologic agents brought up the discussion about the role of NSAIDs in the management of these patients. The objective of this guideline is to provide recommendations for the use of NSAIDs for the treatment of axSpA. A panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis of randomized clinical trials for 15 predefined questions. The Grading of Recommendations, Assessment, Development and Evaluation methodology to assess the quality of evidence and formulate recommendations were used, and at least 70% agreement of the voting panel was needed. Fourteen recommendations for the use of NSAIDs in the treatment of patients with axSpA were elaborated. The purpose of these recommendations is to support clinicians’ decision making, without taking out his/her autonomy when prescribing for an individual patient.